-
Effects of Tp53 Gene Mutations on the Survival of Non-Small Cell Lung Cancer (NSCLC); A Short Review
15 Jan 2025 11:59 GMT
… behavior and a worse overall survival rate may be associated with … score at admission, as significant survival influencers. Multivariate analysis pinpointed elevated … genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene …
-
Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma
24 Jan 2025 12:04 GMT
… 2024. The five-year relative survival rate for patients diagnosed with advanced … , or IIIA NSCLC.
Malignant Pleural Mesothelioma
KEYTRUDA, in combination with pemetrexed … advanced or metastatic malignant pleural mesothelioma (MPM).
Head and Neck Squamous …
-
Discovery in mesothelioma research may increase patient survival rate
22 Nov 2024 22:35 GMT
A groundbreaking study of an innovative treatment published in February this year in the JAMA Oncology, a peer-reviewed medical journal, brings long-awaited advancements in mesothelioma research. The international research team found that chemotherapy …
-
Life-Saving Options for Metastatic Advanced Cancer Treatment: Check Top HIPEC/PIPAC Doctors & Clinics Worldwide
23 Jan 2025 10:56 GMT
… treating cancers such as peritoneal mesothelioma, ovarian cancer, and … reported a 3-year survival rate of approximately 24% for … condition.
5. Peritoneal Mesothelioma
A rare cancer originating … of the abdomen, peritoneal mesothelioma can benefit from HIPEC …
-
Merck Announces Phase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Advanced Epithelial Ovarian Cancer
09 Dec 2024 12:13 GMT
… primary endpoint of progression-free survival (PFS). At the final analysis … , or IIIA NSCLC.
Malignant Pleural Mesothelioma
KEYTRUDA, in combination with pemetrexed … economic factors, including interest rate and currency exchange rate fluctuations; the impact …
-
Is Mesothelioma Always Fatal?
18 Nov 2024 16:16 GMT
… Mesothelioma
The prognosis for mesothelioma describes the expected health outcome for patients. Survival rate … .
The overall 5-year mesothelioma survival rate is 12%, meaning 12% … important to note that mesothelioma survival rates are merely estimates …
-
Merck gets positive EU CHMP opinion for Keytruda plus Chemotherapy as first-line treatment for adult patients with unresectable non-eithelioid Malignant Pleural Mesothelioma
19 Nov 2024 09:48 GMT
… with non-epithelioid mesothelioma, who experience worse survival outcomes than patients … with epithelioid mesothelioma,” said Dr. … 7.7], respectively). Overall response rate (ORR) was significantly higher …
-
CHMP Recommends First-Line Pembrolizumab Plus Chemo for Unresectable Non-Epithelioid Malignant Pleural Mesothelioma
15 Nov 2024 19:14 GMT
… = .0194).1 The overall response rate (ORR) was 52% (95% CI … Europe with non-epithelioid mesothelioma, who experience worse survival outcomes than patients … with epithelioid mesothelioma,” Gregory Lubiniecki, …
-
Pembrolizumab/Chemo Earns Positive EU CHMP Opinion in Mesothelioma
15 Nov 2024 18:44 GMT
… with non-epithelioid mesothelioma, who experience worse survival outcomes than patients … with epithelioid mesothelioma,” Gregory Lubiniecki, … chemotherapy produced an objective response rate (ORR) of 52% (95% …
-
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Non-Epithelioid Malignant Pleural Mesothelioma (MPM)
15 Nov 2024 12:26 GMT
… with non-epithelioid mesothelioma, who experience worse survival outcomes than patients … with epithelioid mesothelioma,” said Dr. … 7.7], respectively). Overall response rate (ORR) was significantly higher …
About
© 1995-2025